Home   >  
Microbiology/Virology
  >  
Antibiotic
  >   Oritavancin diphosphate
Oritavancin diphosphate Chemical Structure

Oritavancin diphosphate

Data Sheet For research use only. Not for human use.
Cat. No. :BCP24660CAS No. :192564-14-0Purity:98%
 Tel: 0086-17754423994   or   orders@biochempartner.com
Real-Time Inquiry ×

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • Chemical Properties&Biological Activity
CAS No. 192564-14-0 Cat. No. BCP24660
Name Oritavancin diphosphate
Synonyms LY333328 diphosphate; LY-333328 diphosphate; LY 333328 diphosphate;
SMILES
Chemical Name
Formula C86H103Cl3N10O34P2 M. Wt 1989.1
Purity 98% Storage Store at 4-8°C
Description Oritavancin diphosphate is a novel semisynthetic glycopeptide antibiotic being developed for the treatment of serious Gram-positive bacterial infections.Oritavancin, also known as LY333328, is a novel semisynthetic glycopeptide antibiotics. On August 6, 2014, the FDA approved oritavancin for treatment of skin infections. Oritavancin possesses potent and rapid bactericidal activity in vitro against a broad spectrum of both resistant and susceptible Gram-positive bacteria, including Staphylococcus aureus, MRSA, enterococci, and streptococci. Oritavancin was more active than either metronidazole or vancomycin against strains of Clostridium difficile tested. Oritavancin has potential use as a therapy for exposure to Bacillus anthracis, the Gram-positive bacterium that causes anthrax, having demonstrated efficacy in a mouse model both before and after exposure to the bacterium. The 4'-chlorobiphenylmethyl group disrupts the cell membrane of Gram-positive bacteria. It also acts by inhibition of transglycosylation and inhibition of transpeptidation.
  • Quality Control&Technical Support
In the process of purchasing and using Biochempartner products, you can consult us if you have any problems: orders@biochempartner.com. We will try our best to solve all your doubts.

Recommend Products

More >

Tags:Oritavancin diphosphate supplier,Oritavancin diphosphate purchase,Oritavancin diphosphate manufacturer,Oritavancin diphosphate distributor,Oritavancin diphosphate cost,Oritavancin diphosphate buy,Oritavancin diphosphate for sale

0086-13720134139